https://allsci.com/news/funding/skye-bioscience-redx-pharma-acquisition/ AllScien 2026-08-14T16:15:10.332221Z Redx takes control of Skye in Nasdaq combination backed by USD 125m financing https://allsci.com/news/clinical-trials/car-t-lupus-nephritis-fate-advances-first/ AllScien 2026-08-14T16:02:17.883614Z Fate takes off-the-shelf CAR T into potentially registrational lupus nephritis trial https://allsci.com/news/research/neurodevelopmental-disorder-gene-therapy/ AllScien 2026-08-14T15:18:00.736681Z MGH, Harvard researchers restore PV neuron function, suppress seizures in NDD mouse model https://allsci.com/news/research/candida-auris-vaccine-synthetic-mannan-epitope/ AllScien 2026-08-14T15:05:10.062809Z Synthetic glycan opens vaccine route against Candida auris https://allsci.com/news/approvals/tau-pet-imaging-alzheimers-fda-approves-lantheuss/ AllScien 2026-08-14T14:46:06.264056Z US FDA approves Lantheus’ Tauklarify as second tau PET tracer for Alzheimer’s disease https://allsci.com/news/grants/amd-gene-therapy-grant-oculogenex-secures-109m/ AllScien 2026-08-14T13:44:11.751476Z Oculogenex secures NEI grant as AMD gene therapy nears IND https://allsci.com/news/approvals/felzartamab-approval-china-wins-first-global-for/ AllScien 2026-08-14T13:28:37.992962Z Biogen's felzartamab wins first global approval in China for multiple myeloma https://allsci.com/news/licensing-and-partnerships/atrium-therapeutics-bms-milestone-collects-second/ AllScien 2026-08-14T11:03:42.299321Z Atrium collects second USD 15m milestone from BMS as cardiovascular RNA programs advance https://allsci.com/news/licensing-and-partnerships/cspc-astrazeneca-sirna-collaboration-secures-usd/ AllScien 2026-08-14T10:58:47.532153Z CSPC secures USD 30m from AstraZeneca for siRNA renal disease platform collaboration https://allsci.com/news/funding/maplight-therapeutics-funding-secures-usd-150m-to/ AllScien 2026-08-14T10:56:19.126101Z MapLight bags USD 150m after muscarinic schizophrenia Phase II win https://allsci.com/news/funding/azenosertib-ovarian-cancer-funding-zentalis/ AllScien 2026-08-14T10:50:44.130339Z Zentalis adds USD 80.5m as azenosertib nears pivotal test https://allsci.com/news/venture-financing/oral-immunology-funding-khartis-therapeutics/ AllScien 2026-08-14T10:33:15.517831Z Khartis bags USD 95m for oral challenger to Tepezza https://allsci.com/news/regulatory/fda-alzheimers-inhaled-cromolyn-clears-phenonets/ AllScien 2026-08-14T10:20:37.534761Z PhenoNet revives inhaled cromolyn for Phase III Alzheimer’s test https://allsci.com/news/regulatory/lyme-disease-vaccine-ema-begins-review-of/ AllScien 2026-08-14T10:13:26.564860Z Pfizer, Valneva Lyme vaccine enters EU review after Phase III https://allsci.com/news/approvals/zenbexus-fda-approval-multiple-myeloma-grants/ AllScien 2026-08-14T09:58:19.668869Z BMS scores first CELMoD approval as FDA embraces MRD surrogate https://allsci.com/news/clinical-trials/epaminurad-gout-trial-jw-pharmaceuticals-beats/ AllScien 2026-08-14T09:53:04.625527Z JW sets up epaminurad partnering push with Phase III gout win https://allsci.com/news/first-in-human-trials/crispr-gene-therapy-hypertension-initiates/ AllScien 2026-08-14T09:13:21.476168Z CRISPR Therapeutics takes one-shot gene editing into hypertension https://allsci.com/news/grants/cancer-dark-proteome-dana-farber-receives-116m/ AllScien 2026-08-13T17:13:46.074553Z Cancer's 'dark proteome' becomes new hunting ground for drug targets https://allsci.com/news/corporate-strategy/iaso-bio-medisix-acquisition-car-t-acquires-to/ AllScien 2026-08-13T17:04:39.541003Z IASO Bio acquires MediSix to expand CAR-T reach into T-cell malignancies https://allsci.com/news/clinical-trials/pht-776-phase-i-trial-photys-and-polymed-initiate/ AllScien 2026-08-13T16:59:14.308971Z Photys and Polymed put oral IRAK4 PROTAC degrader into first-in-human https://allsci.com/news/licensing-and-partnerships/adc-licensing-greater-china-allist-licenses/ AllScien 2026-08-13T16:53:15.810213Z ArriVent hands Allist Greater China rights to MUC16/NaPi2b ADC https://allsci.com/news/regulatory/fda-clearance-ykyy033-youcare-pharmaceuticals/ AllScien 2026-08-13T16:38:32.708502Z Youcare takes Factor XI siRNA into US anticoagulation race https://allsci.com/news/licensing-and-partnerships/msd-inventisbio-oncology-collaboration-and-team/ AllScien 2026-08-13T14:19:12.795305Z MSD's China Innovation Center taps InventisBio for small-molecule oncology https://allsci.com/news/grants/allogeneic-cell-therapies-blood-cancer-university/ AllScien 2026-08-13T11:57:28.173380Z NCI backs Minnesota's off-the-shelf cancer-killing Treg platform https://allsci.com/news/safety-issues-crls/vykat-xr-safety-deaths-pws-organizations-call-for/ AllScien 2026-08-13T11:47:19.274781Z Patient groups raise alarm over Vykat XR use after seven deaths reported https://allsci.com/news/first-in-human-trials/sf3b1-mutant-mds-treatment-regeneron-enters-with/ AllScien 2026-08-13T11:24:32.467526Z Regeneron quietly takes SF3B1-mutant therapy into first-in-human trial https://allsci.com/news/regulatory/fda-fast-track-parkinsons-vaccine-grants-status/ AllScien 2026-08-13T11:02:41.938351Z AC Immune takes Parkinson's vaccine into US trials as Phase II data near https://allsci.com/news/finance/sangamo-bankruptcy-auction-sangamos-yields-usd/ AllScien 2026-08-13T10:07:34.521811Z PTC, Lilly scoop up Sangamo gene therapies in bankruptcy auction https://allsci.com/news/funding/boulevard-bio-funding-emerges-from-deerfield-with/ AllScien 2026-08-13T09:45:24.538860Z Boulevard Bio launches with Deerfield backing for IgAN pipeline https://allsci.com/news/strategic-financing/zealand-pharma-rusfertide-royalty-converts-legacy/ AllScien 2026-08-13T09:16:16.599445Z Zealand cashes out rusfertide royalty for USD 100m ahead of FDA decision https://allsci.com/news/clinical-trials/zipalertinib-egfr-exon-20-insertion-plus/ AllScien 2026-08-13T09:11:11.640344Z Zipalertinib Phase III win sets up first-line Rybrevant challenge